David Kavanagh
David Kavanagh is the Acting General Manager of IROS, and he emphasizes the significance of translating a decade of genomic investment in the UAE into practical clinical research, particularly through the pioneering Alzheimer's prevention trial that utilizes insights from the UAE Genome Program.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Arab Emirates | 1 | 8.00 | 0.08% | +0% | 9,890,400 | 7,976 | $430,000 | 347$ |
| Totals | 1 | 9,890,400 | 7,976 | $430,000 | 347$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Arab Emirates:
David Kavanagh, the Acting General Manager of IROS, stated that the trial represents a clinical translation of a decade of investment in genomics in the UAE.
8